Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation-Reference-Cited by-同舟云学术

Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation

Published:2015-12 Issue:1 Volume:12 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Mazzola Maria Antonietta,Raheja Radhika,Murugaiyan Gopal,Rajabi Hasan,Kumar Deepak,Pertel Thomas,Regev Keren,Griffin Russell,Aly Lilian,Kivisakk Pia,Nejad Parham,Patel Bonny,Gwanyalla Nguendab,Hei Hillary,Glanz Bonnie,Chitnis Tanuja,Weiner Howard L.,Gandhi Roopali

Funder

Novartis Pharmaceuticals Corporation

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1186/s12974-015-0460-z

Reference68 articles.

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–17.

2. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain. 2009;132:3329–41.

3. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol. 2009;183:7169–77.